Your browser doesn't support javascript.
loading
Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disorders.
Moore, Fang; Wang, Wei; Zhao, Guohua; Mignone, James; Meng, Wei; Chu, Ching-Hsuen; Ma, Zhengping; Azzara, Anthony; Cullen, Mary Jane; Pelleymounter, Mary Ann; Appiah, Kingsley; Cvijic, Mary Ellen; Dierks, Elizabeth; Chang, Shu; Foster, Kimberly; Kopcho, Lisa; O'Malley, Kevin; Li, Yi-Xin; Khandelwal, Purnima; Whaley, Jean M; Mathur, Arvind; Hou, Xiaoping; Wu, Dauh-Rurng; Robl, Jeffrey A; Cheng, Dong; Devasthale, Pratik.
Afiliação
  • Moore F; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Wang W; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Zhao G; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Mignone J; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Meng W; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Chu CH; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Ma Z; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Azzara A; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Cullen MJ; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Pelleymounter MA; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Appiah K; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Cvijic ME; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Dierks E; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Chang S; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Foster K; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Kopcho L; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • O'Malley K; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Li YX; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Khandelwal P; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Whaley JM; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Mathur A; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Hou X; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Wu DR; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Robl JA; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Cheng D; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States.
  • Devasthale P; Bristol Myers Squibb Research & Development, P.O. Box 4000, Princeton, NJ, 08543, United States. Electronic address: pratik.devasthale@bms.com.
Bioorg Med Chem Lett ; 91: 129362, 2023 07 15.
Article em En | MEDLINE | ID: mdl-37295614
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monoglicerídeos / Doenças Metabólicas Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Monoglicerídeos / Doenças Metabólicas Limite: Humans Idioma: En Revista: Bioorg Med Chem Lett Assunto da revista: BIOQUIMICA / QUIMICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos